Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives

by Bas Weenink, Pim J. French, Peter A.E. Sillevis Smitt, Reno Debets, Marjolein Geurts
Published 2020-03-01

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens

by Bas Weenink, Kaspar Draaisma, Han Z. Ooi, Johan M. Kros, Peter A. E. Sillevis Smitt, Reno Debets, Pim J. French
Published 2019-10-01

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics

by Martijn M. VanDuijn, Lennard J. Dekker, Wilfred F. J. van IJcken, Peter A. E. Sillevis Smitt, Theo M. Luider
Published 2017-10-01

Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

by Marcel P Stoop, Vaibhav Singh, Lennard J Dekker, Mark K Titulaer, Christoph Stingl, Peter C Burgers, Peter A E Sillevis Smitt, Rogier Q Hintzen, Theo M Luider
Published 2010-01-01

IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis.

by Ya Gao, Maurice de Wit, Eduard A Struys, Herma C Z van der Linde, Gajja S Salomons, Martine L M Lamfers, Rob Willemsen, Peter A E Sillevis Smitt, Pim J French
Published 2018-01-01

Peptides from the variable region of specific antibodies are shared among lung cancer patients.

by Dominique de Costa, Ingrid Broodman, Wim Calame, Christoph Stingl, Lennard J M Dekker, René M Vernhout, Harry J de Koning, Henk C Hoogsteden, Peter A E Sillevis Smitt, Rob J van Klaveren, Theo M Luider, Martijn M Vanduijn
Published 2014-01-01

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

by Anna E. M. Bastiaansen, A. Mieke Timmermans, Marcel Smid, Carolien H. M. van Deurzen, Esther S. P. Hulsenboom, Wendy J. C. Prager-van der Smissen, Renée Foekens, Anita M. A. C. Trapman-Jansen, Peter A. E. Sillevis Smitt, Theo M. Luider, John W. M. Martens, Martijn M. vanDuijn
Published 2020-12-01